Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
26th May 2015 7:01 am RNS UPDATE ON BRODALUMAB DEVELOPMENT PROGRAMME
18th May 2015 10:07 am RNS AstraZeneca to invest £182m to expand drug plant in Sweden
13th May 2015 3:00 pm RNS Holding(s) in Company
8th May 2015 2:00 pm RNS Director/PDMR Shareholding
8th May 2015 11:00 am RNS Director/PDMR Shareholding - Replacement
8th May 2015 10:00 am RNS Director/PDMR Shareholding
7th May 2015 2:00 pm RNS Director Declaration
1st May 2015 4:00 pm RNS Director/PDMR Shareholding
1st May 2015 11:00 am RNS Total Voting Rights
29th Apr 2015 5:30 pm RNS Director/PDMR Shareholding
24th Apr 2015 5:30 pm RNS Result of AGM
24th Apr 2015 7:02 am RNS 1st Quarter Results
24th Apr 2015 7:01 am RNS Collaboration with Celgene on PD-L1 in haematology
24th Apr 2015 7:00 am RNS AZ and Innate to collaborate in immuno-oncology
23rd Apr 2015 9:00 am RNS Notice of Results
17th Apr 2015 7:00 am RNS Selumetinib granted Orphan Drug Designation by FDA
15th Apr 2015 7:02 am RNS Tremelimumab granted Orphan Drug Designation
15th Apr 2015 7:00 am RNS FDA REVIEWS SAVOR OUTCOMES STUDY RESULTS
1st Apr 2015 11:00 am RNS Total Voting Rights
30th Mar 2015 3:00 pm RNS Director/PDMR Shareholding
19th Mar 2015 11:00 am RNS Notice of AGM
19th Mar 2015 7:00 am RNS COLLABORATION WITH DAIICHI SANKYO INC
18th Mar 2015 7:04 am RNS POSITIVE PHASE III RESULTS FOR PT003 IN COPD
16th Mar 2015 7:00 am RNS BRILINTA PEGASUS-TIMI 54 STUDY
10th Mar 2015 6:24 pm RNS Filing of Form 20-F with SEC
10th Mar 2015 11:00 am RNS Annual Financial Report
6th Mar 2015 7:00 am RNS ASTRAZENECA REFINES ITS FINANCIAL REPORTING
4th Mar 2015 11:54 am RNS AZ TO PARTICIPATE IN US FDA EMDAC
3rd Mar 2015 7:05 am RNS Acquisition of Rights to Actavis' Portfolio
2nd Mar 2015 3:00 pm RNS Total Voting Rights
17th Feb 2015 7:00 am RNS Directorate Change
16th Feb 2015 7:00 am RNS PULMICORT RESPULES® US PATENT LITIGATION DECISION
5th Feb 2015 7:02 am RNS AZ to acquire Actavis' US respiratory portfolio
5th Feb 2015 7:00 am RNS Final Results
4th Feb 2015 9:00 am RNS Notice of Results
2nd Feb 2015 2:00 pm RNS Total Voting Rights
22nd Jan 2015 7:00 am RNS MAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMA
14th Jan 2015 7:43 am RNS BRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINT
2nd Jan 2015 2:00 pm RNS Total Voting Rights
19th Dec 2014 5:40 pm RNS LYNPARZA APPROVED BY THE US FDA
FTSE 100 Latest
Value8,275.66
Change0.00